patientshareholders

215 results found.

Top Stocks matching your search for "patient shareholders"

Click Learn More to know about Stock Advisor's top picks. We've 3x'd the S&P 500 over the last 20 years.

02/0902/1402/1702/2302/2803/0303/0803/1303/1603/21
XERS

Xeris Biopharma Holdings Inc

15.52%

$1.16 - $1.34

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Jan, 12, 2023

$XERS On Gvoke, "better than expected growth&... See more

Nov, 4, 2022

QoQ growth would still increase by ~40% with no new patients.

02/0902/1402/1702/2302/2803/0303/0803/1303/1603/21
PALI

Palisade Bio Inc

-19.56%

$2.25 - $1.81

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Feb, 1, 2023

$PALI patients ⏰⏰⏰

Jan, 23, 2023

$PALI patients are in high gear 🤑🤑🤑

Image with triangles

Divihomes is Now Live

A new search platform that matches you with the best home improvement service providers in your area.

Instant Search & Match with Top Contractors

Instant Communication with Local Contractors

Phone Image with DiviHomes website

Millions of Unbiased User Reviews

100% Free Quotes from Top-Notch Contractors

02/1002/1502/2102/2403/0103/0603/0903/1403/1703/22
HKD

AMTD Digital Inc - ADR

-24.37%

$9.48 - $7.17

Feb 8th 2023 - Mar 22nd 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Jan, 5, 2023

I’m sure patient will rewards high.

Nov, 11, 2022

$HKD I wonder how long they will hold it I’m super... See more

XERS

Xeris Biopharma Holdings Inc

15.52%

$1.16 - $1.34

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Jan, 12, 2023

$XERS On Gvoke, "better than expected growth": "Opportunity remains huge, and you don't have to find patients.

Nov, 4, 2022

QoQ growth would still increase by ~40% with no new patients.

Oct, 20, 2022

Newest product Recorlev just rolled out Q1, huge potential, new best in class treatment for advanced Cushings.

Oct, 20, 2022

Newest product Recorlev just rolled out Q1, huge potential, new best in class treatment for advanced Cushings.

Oct, 20, 2022

Newest product Recorlev just rolled out Q1, huge potential, new best in class treatment for advanced Cushings.

Oct, 20, 2022

Newest product Recorlev just rolled out Q1, huge potential, new best in class treatment for advanced Cushings.

Oct, 20, 2022

Newest product Recorlev just rolled out Q1, huge potential, new best in class treatment for advanced Cushings.

Oct, 20, 2022

Newest product Recorlev just rolled out Q1, huge potential, new best in class treatment for advanced Cushings.

Oct, 20, 2022

Newest product Recorlev just rolled out Q1, huge potential, new best in class treatment for advanced Cushings.

PALI

Palisade Bio Inc

-19.56%

$2.25 - $1.81

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Feb, 1, 2023

$PALI patients ⏰⏰⏰

Jan, 23, 2023

$PALI patients are in high gear 🤑🤑🤑

Oct, 5, 2022

Conclusion: For patients undergoing elective bowel resection surgery, LB1148 was safe and well-tolerated and significantly accelerated the return of bowel function.

HKD

AMTD Digital Inc - ADR

-24.37%

$9.48 - $7.17

Feb 8th 2023 - Mar 22nd 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Jan, 5, 2023

I’m sure patient will rewards high.

Nov, 11, 2022

$HKD I wonder how long they will hold it I’m super patient I will be holding & adding more by days I’m not leaving 😂 soon or later it will eventually explode 🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀